Manufacturer celebrates five years of real-time continuous glucose monitoring
As recently reported, Dexcom published a study in Diabetes Therapy providing evidence to back up use of rtCGM devices for people with type 2 diabetes following previous research that suggested their technology was cost-effective for people with type 1 diabetes in 2020 in the UK.
Listen to the DRWF Podcast interview with Jake Leach, chief operating officer of CGM development and manufacturing at Dexcom here
If you would like to hear some of the leading CGM experts talk about the most recent advances in this technology, please register for our United Through Diabetes event.
Professor Partha Kar, Consultant Endocrinologist and National Specialty Advisor for Diabetes and Dr Iain Cranston, Consultant Physician in Diabetes and Endocrinology both from Portsmouth Hospitals NHS Trust along with leading industry experts from Dexcom, Abbott, Insulet and Advanced Therapeutics (Dana-i) are just a few of the many key opinion leaders that will be exhibiting and holding CGM and Closed Loop workshops at this very special event on Saturday 16th September at Chesford Grange, Kenilworth, Warwickshire.
Places limited: Don’t miss the opportunity to be part of the conversation – register now!
I would like to make a regular donation of
I would like to make a single donation of